Literature DB >> 21784953

Association of census tract-level socioeconomic status with disparities in prostate cancer-specific survival.

Vincent L Freeman1, Ana C Ricardo, Richard T Campbell, Richard E Barrett, Richard B Warnecke.   

Abstract

BACKGROUND: Social determinants of prostate cancer survival and their relation to racial/ethnic disparities thereof are poorly understood. We analyzed whether census tract-level socioeconomic status (SES) at diagnosis is a prognostic factor in men with prostate cancer and helps explain racial/ethnic disparities in survival.
METHODS: We used a retrospective cohort of 833 African American and white, non-Hispanic men diagnosed with prostate cancer at four Chicago area medical centers between 1986 and 1990. Tract-level concentrated disadvantage (CD), a multidimensional area-based measure of SES, was calculated for each case, using the 1990 U.S. census data. Its association with prostate cancer-specific survival was measured by using Cox proportional hazard models adjusted for case and tumor characteristics, treatment, and health care system [private sector vs. Veterans Health Administration (VA)].
RESULTS: Tract-level CD associated with an increased risk of death from prostate cancer (highest vs. lowest quartile, HR = 2.37, P < 0.0001). However, the association was observed in the private sector and not in the VA (per 1 SD increase, HR = 1.33, P < 0.0001 and HR = 0.93, P = 0.46, respectively). The multivariate HR for African Americans before and after accounting for tract-level CD was 1.30 (P = 0.0036) and 0.96 (P = 0.82), respectively.
CONCLUSIONS: Census tract-level SES is a social determinant of prostate-specific mortality and helps account for racial/ethnic disparities in survival. An equal-access health care system may moderate this association. IMPACT: This study identifies a potential pathway for minimizing disparities in prostate cancer control. The findings need confirmation in a population-based study. ©2011 AACR

Entities:  

Mesh:

Year:  2011        PMID: 21784953      PMCID: PMC3189295          DOI: 10.1158/1055-9965.EPI-11-0344

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  28 in total

1.  Socioeconomic status and breast cancer incidence in California for different race/ethnic groups.

Authors:  K Yost; C Perkins; R Cohen; C Morris; W Wright
Journal:  Cancer Causes Control       Date:  2001-10       Impact factor: 2.506

2.  Neighborhood structural disadvantage, collective efficacy, and self-rated physical health in an urban setting.

Authors:  Christopher R Browning; Kathleen A Cagney
Journal:  J Health Soc Behav       Date:  2002-12

3.  Exploring neighborhood-level variation in asthma and other respiratory diseases: the contribution of neighborhood social context.

Authors:  Kathleen A Cagney; Christopher R Browning
Journal:  J Gen Intern Med       Date:  2004-03       Impact factor: 5.128

Review 4.  Prostate cancer and race.

Authors:  Otis W Brawley; Ashesh B Jani; Veraj Master
Journal:  Curr Probl Cancer       Date:  2007 May-Jun       Impact factor: 3.187

Review 5.  Investigating Black-White differences in prostate cancer prognosis: A systematic review and meta-analysis.

Authors:  Simon Evans; Chris Metcalfe; Fowzia Ibrahim; Raj Persad; Yoav Ben-Shlomo
Journal:  Int J Cancer       Date:  2008-07-15       Impact factor: 7.396

6.  Prostate cancer in blacks: an update from the American College of Surgeons' patterns of care studies.

Authors:  N Natarajan; G P Murphy; C Mettlin
Journal:  J Surg Oncol       Date:  1989-04       Impact factor: 3.454

7.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

8.  Factors contributing to the racial differences in prostate cancer mortality.

Authors:  Ashutosh Tewari; Wolfgang Horninger; Alexandre E Pelzer; Raymond Demers; E David Crawford; Eduard J Gamito; George Divine; Christine Cole Johnson; George Bartsch; Mani Menon
Journal:  BJU Int       Date:  2005-12       Impact factor: 5.588

Review 9.  Social disparities and prostate cancer: mapping the gaps in our knowledge.

Authors:  Timothy Gilligan
Journal:  Cancer Causes Control       Date:  2005-02       Impact factor: 2.506

Review 10.  Cancer disparities by race/ethnicity and socioeconomic status.

Authors:  Elizabeth Ward; Ahmedin Jemal; Vilma Cokkinides; Gopal K Singh; Cheryll Cardinez; Asma Ghafoor; Michael Thun
Journal:  CA Cancer J Clin       Date:  2004 Mar-Apr       Impact factor: 508.702

View more
  18 in total

1.  Second opinions from urologists for prostate cancer: Who gets them, why, and their link to treatment.

Authors:  Archana Radhakrishnan; David Grande; Nandita Mitra; Justin Bekelman; Christian Stillson; Craig Evan Pollack
Journal:  Cancer       Date:  2016-11-07       Impact factor: 6.860

2.  Determinants of Clinic Absenteeism: A Novel Method of Examining Distance from Clinic and Transportation.

Authors:  Ryan W Dobbs; Neha R Malhotra; Brandon M Caldwell; Raymond Rojas; Daniel M Moreira; Michael R Abern
Journal:  J Community Health       Date:  2018-02

3.  When Primary Care Providers (PCPs) Help Patients Choose Prostate Cancer Treatment.

Authors:  Archana Radhakrishnan; David Grande; Michelle Ross; Nandita Mitra; Justin Bekelman; Christian Stillson; Craig Evan Pollack
Journal:  J Am Board Fam Med       Date:  2017 May-Jun       Impact factor: 2.657

4.  Genetic ancestry and prostate cancer susceptibility SNPs in Puerto Rican and African American men.

Authors:  Margarita Irizarry-Ramírez; Rick A Kittles; Xuemei Wang; Jeannette Salgado-Montilla; Graciela M Nogueras-González; Ricardo Sánchez-Ortiz; Lourdes Guerrios; Keila Rivera; Ebony Shah; Ina Prokhorova; Pamela Roberson; Patricia Troncoso; Curtis A Pettaway
Journal:  Prostate       Date:  2017-05-24       Impact factor: 4.104

5.  The influence of neighborhood socioeconomic status and race on survival from ovarian cancer: a population-based analysis of Cook County, Illinois.

Authors:  Katherine C Brewer; Caryn E Peterson; Faith G Davis; Kent Hoskins; Heather Pauls; Charlotte E Joslin
Journal:  Ann Epidemiol       Date:  2015-04-18       Impact factor: 3.797

6.  Essential elements of personalized medicine.

Authors:  Wylie Burke; Susan Brown Trinidad; Nancy A Press
Journal:  Urol Oncol       Date:  2013-12-08       Impact factor: 3.498

7.  Impact of chronic conditions on the cost of cancer care for Medicaid beneficiaries.

Authors:  Sujha Subramanian; Florence K L Tangka; Susan A Sabatino; David Howard; Lisa C Richardson; Susan Haber; Michael T Halpern; Sonja Hoover
Journal:  Medicare Medicaid Res Rev       Date:  2013-01-17

8.  Disparities in Adolescent and Young Adult Survival After Testicular Cancer Vary by Histologic Subtype: A Population-Based Study in California 1988-2010.

Authors:  Mindy C DeRouen; Mahasin Mujahid; Sandy Srinivas; Theresa H M Keegan
Journal:  J Adolesc Young Adult Oncol       Date:  2015-11-18       Impact factor: 2.223

9.  The effect of neighborhood disadvantage on the racial disparity in ovarian cancer-specific survival in a large hospital-based study in cook county, illinois.

Authors:  Caryn E Peterson; Garth H Rauscher; Timothy P Johnson; Carolyn V Kirschner; Sally Freels; Richard E Barrett; Seijeoung Kim; Marian L Fitzgibbon; Charlotte E Joslin; Faith G Davis
Journal:  Front Public Health       Date:  2015-01-22

10.  Design of a prostate cancer patient navigation intervention for a Veterans Affairs hospital.

Authors:  Narissa J Nonzee; June M McKoy; Alfred W Rademaker; Peter Byer; Thanh Ha Luu; Dachao Liu; Elizabeth A Richey; Athena T Samaras; Genna Panucci; XinQi Dong; Melissa A Simon
Journal:  BMC Health Serv Res       Date:  2012-09-25       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.